Latest update:
Wednesday, August 17, 2016 - 16:08
22 April 2025 | Sales revenues for March 2025 |
20 March 2025 | Sales revenues for February 2025 |
20 February 2025 | Sales revenues for January 2025 |
20 December 2024 | Decision on additional contribution to the capital of Sopharma Rus OOO | |||
19 December 2024 | Transaction within the scope of art. 114, para. 2 of the Law on Public offering of securities | |||
19 December 2024 | Sales revenues for November 2024 |
29 November 2024 | Notification for Initiation of acquisition transaction | |||
20 November 2024 | Sales revenues for October 2024 |
20 September 2024 | Sales revenues for August 2024 | |||
9 September 2024 | Notification of sale of treasury shares as of 9 September 2024 |
20 August 2024 | Sales revenues for July 2024 | |||
19 August 2024 | "Sopharma" AD starts the payment of the dividend for 2023 on August 26, 2024 |
22 July 2024 | Sales revenues for June 2024 | |||
1 July 2024 | Notification of sale of treasury shares as of 1 July 2024 |
21 May 2024 | Sales revenues for April 2024 |
22 April 2024 | Sales revenues for March 2024 |
|
20 March 2024 | Sales revenues for February 2024 |
27 February 2024 | Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212 | |||
19 February 2024 | Sales revenues for January 2024 |
24 November 2023 | Notification on the terms and conditions for distribution of the dividend | |||
20 November 2023 | Sales revenues for October 2023 | |||
7 November 2023 | Serbian Commission for Protection of Competition allowed deal with Pharmanova |
20 October 2023 | Sales revenues for September 2023 | |||
16 October 2023 | Notification for a significant shareholding from CUPF Alianz Bulgaria | |||
16 October 2023 | Optimization of the activity in foreign markets | |||
13 October 2023 | Notification for a significant shareholding from “Telecomplect Invest” AD | |||
13 October 2023 | Notification for a significant shareholding from Ognian Donev | |||
6 October 2023 | New capital of "Sopharma" AD entered in the Commercial Register | |||
2 October 2023 | Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212 |
22 May 2023 | Sales revenues for April 2023 |
20 April 2023 | Sales revenues for March 2023 |
20 March 2023 | Sales revenues for February 2023 |
21 February 2023 | Notification for share participation from “Telso” AD | |||
21 February 2023 | Notification for share participation from “Donev investments holding” AD | |||
6 February 2023 | Sales revenues for January 2023 | |||
1 February 2023 | Dissimination of monthly sales information |
5 December 2022 | Sales revenues for November 2022 |
29 November 2022 | Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS | |||
28 November 2022 | Tender offer to the shareholders of “Sopharma” AD by “Donev Investments Holding” AD | |||
7 November 2022 | Sales revenues for October 2022 |
26 October 2022 | Merger of the subsidiary "Biopharm-engineering" AD into "Sopharma" AD | |||
5 October 2022 | Sales revenues for September 2022 |
29 September 2022 | Shareholding notification from “Telso” AD | |||
7 September 2022 | Sales revenues for August 2022 |
26 August 2022 | Results of the tender offering extended to the shareholders of “Sopharma Properties” REIT | |||
5 August 2022 | Sales revenues for July 2022 |
14 June 2022 | Treasury shares | |||
10 June 2022 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||
7 June 2022 | Treasury shares | |||
6 June 2022 | Sales revenues for May 2022 | |||
3 June 2022 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares |
5 May 2022 | Sales revenues for April 2022 |
5 April 2022 | Sales revenues for March 2022 |
7 March 2022 | Sales revenues for February 2022 | |||
1 March 2022 | Conclusion of transactions from the scope of art. 114, para. 2 of the LPOS |
7 February 2022 | Sales revenues for January 2022 |
30 December 2021 | The subscription for the public offering of warrants is successfully completed | |||
23 December 2021 | Sale of the share in the capital of the subsidiary SIA „Briz“ | |||
21 December 2021 | Notification for share participation from “Rompharm Company” OOD | |||
6 December 2021 | Sales revenues for November 2021 | |||
6 December 2021 | Treasury shares | |||
2 December 2021 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||
2 December 2021 | Treasury shares |
30 November 2021 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||
5 November 2021 | Sales revenues for October 2021 | |||
5 November 2021 | Notification under Art. 89t of LPOS regarding public offering of warrants by “Sopharma” AD |
5 October 2021 | Sales revenues for September 2021 |
30 September 2021 | Treasury shares | |||
28 September 2021 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||
27 September 2021 | Treasury shares | |||
23 September 2021 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||
20 September 2021 | Treasury shares | |||
16 September 2021 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||
13 September 2021 | Treasury shares | |||
13 September 2021 | Treasury shares | |||
9 September 2021 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||
9 September 2021 | Sales revenues for August 2021 | |||
7 September 2021 | Treasury shares | |||
2 September 2021 | Notification under Art. 111 para. 6 of LPOS for repurchase of shares |
5 August 2021 | Sales revenues for July 2021 | |||
3 August 2021 | The Board of Directors of „Sopharma“ AD approved a prospectus for the issue of warrants |
5 July 2021 | Sales revenues for June 2021 |
7 June 2021 | Sales revenues for May 2021 | |||
1 June 2021 | Annual General Meeting of Shareholders convened for 4 June 2021 from 11:00 a.m. (8:00 a.m. UTC) |
21 May 2021 | The Board of Directors of “Sopharma” AD adopted a decision to issue warrants | |||
13 May 2021 | Sales revenues for April 2021 |
5 April 2021 | Sales revenues for March 2021 |
|
||
2 April 2021 | Notification on the adoption of a decision for amendments to the Articles of Association of the Company |
5 February 2021 | Sales revenues for January 2021 |
11 January 2021 | Sales revenues for December 2020 | |||
8 January 2021 | „Sopharma” AD now owns 100% of the capital of the subsidiary BRIZ, Latvia |
16 November 2020 | W dniu 23. listopada 2020 spółka Sopharma S.A. rozpoczyna wypłatę dywidendy 6-miesięcznej | |||
5 November 2020 | Sales revenues for October 2020 |
5 October 2020 | Sales revenues for September 2020 |
30 September 2020 | Notification for acquisition of own shares | |||
28 September 2020 | Notification on the adoption of a new Policy for formation of the remuneration of the members of the Board of Directors of “Sopharma” AD | |||
28 September 2020 | Notification for acquisition of own shares | |||
25 September 2020 | Notification for acquisition of own shares | |||
25 September 2020 | Notification on the terms and conditions for distribution of the dividend | |||
24 September 2020 | Notification for acquisition of own shares | |||
23 September 2020 | Notification for acquisition of own shares | |||
14 September 2020 | Online meeting with investors and exercising the right to vote by correspondence at the Extraordinary General Meetings of Shareholders convened on 25 September, 2020 from 11:00 and 11:30 | |||
8 September 2020 | Sales revenues for August 2020 |
5 August 2020 | Sales revenues for July 2020 |
22 July 2020 | „Sopharma“ AD starts the payment of the gross dividend on August 3, 2020 | |||
7 July 2020 | Notification for technical error correction | |||
6 July 2020 | Sales revenues for June 2020 | |||
1 July 2020 | Notification for acquisition of own shares |
30 June 2020 | Notification for acquisition of own shares | |||
29 June 2020 | Notification for acquisition of own shares | |||
26 June 2020 | Notification for acquisition of own shares | |||
25 June 2020 | Notification for acquisition of own shares | |||
23 June 2020 | Notification for acquisition of own shares | |||
22 June 2020 | Notification for acquisition of own shares | |||
19 June 2020 | Notification for acquisition of own shares | |||
19 June 2020 | Notification for acquisition of own shares | |||
18 June 2020 | Notification for technical error correction | |||
16 June 2020 | The Board of directors of “Sopharma” AD assigned a procurator of the Company | |||
16 June 2020 | Notification for acquisition of own shares | |||
5 June 2020 | Sales revenues for May 2020 | |||
5 June 2020 | Notification on the terms and conditions for distribution of the dividend | |||
2 June 2020 | Notification for acquisition of own shares |
26 May 2020 | Online meeting with investors and exercising the right to vote by correspondence at the General Meeting of Shareholders convened on June 5, 2020 | |||
5 May 2020 | Sales revenues for April 2020 |
5 March 2020 | Sales revenues for February 2020 |
5 February 2020 | Sales revenues for January 2020 |
16 January 2020 | Sopharma AD starts the payment of the 6-month dividend on January 22, 2020 |
Use of cookies
We would like to use cookies to better understand your use of this website. This helps us improve your future experience when visiting our website. If you continue your visit on our website, we shall assume that you agree with the cookies used. Detailed information on the use of cookies on this website and how to manage or withdraw your consent at any time, can be found in our